Insider · CIK 0001826263
Vakiener Victoria
Reports to the SEC for 3 companies · DURHAM, NC
Transactions
28
Companies
3
Filings
12
CIK
0001826263
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-12-19 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$186K |
| 2025-12-19 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$359K |
| 2025-12-19 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$134K |
| 2025-12-16 | ARWRARROWHEAD PHARMACEUTICALS, INC.A Award | — |
| 2025-04-21 | CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-04-21 | CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-04-21 | CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-04-21 | CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-04-21 | CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-12-18 | ARWRARROWHEAD PHARMACEUTICALS, INC.A Award | +$385K |
| 2024-12-16 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$197K |
| 2024-06-20 | CHIMERIX INCStock Option (Right to Buy)A Award | — |
| 2024-05-02 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$41.9K |
| 2024-01-11 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$137K |
| 2024-01-11 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$42.7K |
| 2023-12-15 | ARWRARROWHEAD PHARMACEUTICALS, INC.A Award | +$381K |
| 2023-09-28 | ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale | −$40.8K |
| 2023-06-09 | CHIMERIX INCStock Option (Right to Buy)A Award | — |
| 2023-01-10 | ARWRARROWHEAD PHARMACEUTICALS, INC.D Disposition to Issuer | — |
| 2023-01-10 | ARWRARROWHEAD PHARMACEUTICALS, INC.A Award | — |
| 2023-01-10 | ARWRARROWHEAD PHARMACEUTICALS, INC. · Common StockA Award | — |
| 2022-06-23 | CHIMERIX INCStock Option (Right to Buy)A Award | — |
| 2021-06-23 | CHIMERIX INCStock Option (Right to Buy)A Award | — |
| 2021-04-22 | CHIMERIX INCStock Option (Right to Buy)A Award | — |
| 2021-02-04 | Epizyme, Inc.S Sale | −$9,158.57 |
| 2021-02-01 | Epizyme, Inc.A Award | — |
| 2021-02-01 | Epizyme, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-01-25 | Epizyme, Inc.S Sale | −$6,834.59 |
Recent filings
- 4Vakiener Victoria0001826263-25-000006SEC(opens sec.gov)
- 4Vakiener Victoria0001826263-25-000004SEC(opens sec.gov)
- 4Vakiener Victoria0001415889-25-011082SEC(opens sec.gov)
- 4Vakiener Victoria0001628280-24-052274SEC(opens sec.gov)
- 4Vakiener Victoria0001628280-24-051923SEC(opens sec.gov)
- 4Vakiener Victoria0001415889-24-017774SEC(opens sec.gov)
- 4Vakiener Victoria0001628280-24-020774SEC(opens sec.gov)
- 4Vakiener Victoria0001628280-24-001422SEC(opens sec.gov)
- 4Vakiener Victoria0001628280-23-041963SEC(opens sec.gov)
- 4Vakiener Victoria0001628280-23-033520SEC(opens sec.gov)
- 4Vakiener Victoria0001209191-23-036307SEC(opens sec.gov)
- 4Vakiener Victoria0001209191-23-003079SEC(opens sec.gov)
Companies
Address
C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC, 27713